These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 21919357)

  • 1. Development and validation of an HPLC stability-indicating method for identification and assay of elemental iron(II) in pharmaceutical drug products using reversed-phase HPLC.
    Dias NC; Rustum AM
    J AOAC Int; 2011; 94(4):1233-9. PubMed ID: 21919357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of doxycycline hyclate in tablets by HPLC-UV method.
    Kogawa AC; Salgado HR
    J Chromatogr Sci; 2013; 51(10):919-25. PubMed ID: 23192739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Validation of a Fast Stability-Indicating Ion-Paired Reversed-Phase HPLC Method for the Assay of Thiabendazole and Estimation of Its Related Compounds.
    Zhang P; Tian J; Rustum A
    J AOAC Int; 2017 Jan; 100(1):74-81. PubMed ID: 28825538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a novel stability-indicating reversed-phase high-performance liquid chromatography method for assay of loratadine and determination of its related compounds.
    Lu J; Wei YC; Markovich RJ; Rustum AM
    J AOAC Int; 2010; 93(3):891-903. PubMed ID: 20629392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Method development and validation for the HPLC potency assay of troglitazone tablets.
    Lambropoulos J; Bergholdt AB
    J Pharm Biomed Anal; 2000 Dec; 24(2):251-8. PubMed ID: 11130204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of an HPLC method for mefloquine hydrochloride determination in tablet dosage form.
    Nogueira FH; Goulart Lde P; César Ida C; de Campos LM; Pianetti GA
    J AOAC Int; 2011; 94(4):1089-93. PubMed ID: 21919342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A stability-indicating high performance liquid chromatographic (HPLC) assay for the simultaneous determination of atorvastatin and amlodipine in commercial tablets.
    Mohammadi A; Rezanour N; Ansari Dogaheh M; Ghorbani Bidkorbeh F; Hashem M; Walker RB
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 846(1-2):215-21. PubMed ID: 17010681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of a stability-indicating column high-performance liquid chromatographic assay method for determination of nebivolol in tablet formulation.
    Kachhadia PK; Doshi AS; Joshi HS
    J AOAC Int; 2008; 91(3):557-61. PubMed ID: 18567301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability-indicating RP-HPLC method for the simultaneous determination of escitalopram oxalate and clonazepam.
    Kakde RB; Satone DD; Gadapayale KK; Kakde MG
    J Chromatogr Sci; 2013 Jul; 51(6):490-5. PubMed ID: 23135233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QbD-Based Development and Validation of Novel Stability-Indicating Method for the Assay and Dissolution of Garenoxacin in Garenoxacin Tablets.
    Azhakesan A; Kuppusamy S
    J AOAC Int; 2022 Mar; 105(2):370-378. PubMed ID: 34894249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of validated stability indicating assay method for simultaneous estimation of metformin hydrochloride and vildagliptin by RP-HPLC.
    Satheeshkumar N; Pradeepkumar M; Shanthikumar S; Rao VJ
    Drug Res (Stuttg); 2014 Mar; 64(3):124-9. PubMed ID: 24081820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multivariate development and validation of a stability-indicating HPLC method for the determination of glimepiride in tablets.
    Bonfilio R; Peres C; Salgado HR; De Araújo MB; Tarley CR
    J AOAC Int; 2013; 96(5):960-7. PubMed ID: 24282932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of an HPLC method for quantitation of MDMA in tablets.
    Müller IB; Windberg CN
    J Chromatogr Sci; 2005 Sep; 43(8):434-7. PubMed ID: 16212786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug product.
    Luo Z; Deng Z; Liu Y; Wang G; Yang W; Hou C; Tang M; Yang R; Zhou H
    Talanta; 2015 Jul; 139():67-74. PubMed ID: 25882410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and Validation of a Stability-Indicating Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) Method for Identification, Assay, and Estimation of Related Substances of Ivermectin Drug Substance.
    Wimalasinghe RM; Zhao D; Wang L; Rustum A
    J AOAC Int; 2021 Dec; 104(6):1505-1513. PubMed ID: 34389847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validated stability-indicating RP-HPLC method for the determination of rimonabant in a pharmaceutical dosage form.
    Hurtado FK; Ravanello A; Arend MZ; Wrasse M; Dalmora SL; Rolim CM
    J AOAC Int; 2010; 93(3):869-75. PubMed ID: 20629389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of stability indicating method for the determination of exemestane by reverse phase high performance liquid chromatography.
    Konda B; Tiwari RN; Fegade H
    J Chromatogr Sci; 2011 Sep; 49(8):634-9. PubMed ID: 21859539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A stability-indicating RP-HPLC method for the quantitative analysis of meclizine hydrochloride in tablet dosage form.
    Peraman R; Manikala M; Kondreddy VK; Yiragamreddy PR
    J Chromatogr Sci; 2015; 53(5):793-9. PubMed ID: 25644814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A porous graphitized carbon column HPLC method for the quantification of paracetamol, pseudoephedrine, and chlorpheniramine in a pharmaceutical formulation.
    Kalogria E; Koupparis M; Panderi I
    J AOAC Int; 2010; 93(4):1093-101. PubMed ID: 20922939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and application of a validated HPLC method for the determination of gabapentin and its major degradation impurity in drug products.
    Ciavarella AB; Gupta A; Sayeed VA; Khan MA; Faustino PJ
    J Pharm Biomed Anal; 2007 Apr; 43(5):1647-53. PubMed ID: 17275240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.